iRhythm Technologies

IRTCleader

iRhythm's Zio Patch is the dominant long-term ambulatory cardiac monitor, using AI to analyze 100M+ hours of ECG data and detect atrial fibrillation that short-duration Holter monitors miss.

⇄ Compare

Produk & Pendapatan

Pangsa Pendapatan Produk

Komposisi Pendapatan ($601M)

Data statis (memuat keuangan langsung…)

US Revenue (88%)

International (12%)

Komposisi segmen dan pelanggan utama

Detail produk

Zio Patch (Long-term ECG)92%

Wear-once 14-day continuous ECG patch worn on the chest, with AI-powered arrythmia detection — 100M+ days of data.

Zio Monitor (Short-term)8%

3-day wireless patch for acute symptom monitoring, compatible with existing prescribing workflows.

Hubungan Rantai Pasok

Pelanggan Utama

UnitedHealth Group

Insurance coverage for Zio Patch

Dampak: significant

HCA Healthcare

Hospital Zio adoption

Dampak: significant

Konteks makro dan pasar

헬스케어Berita sektor

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Katalis mendatang

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Berita terkini

Memuat berita...

Analisis AI

Klik "Dapatkan Analisis AI" untuk analisis rantai pasok iRhythm Technologies.

Info Perusahaan

Kantor Pusat

San Francisco, California, USA

Didirikan

2006

Karyawan

1,900

Situs Web

irhythmtech.com

Gambaran umum sektor — 헬스케어

Berita sektor